The function of medication beliefs as mediators between personality traits and adherence behavior in people with asthma

Patient Preference and Adherence

Volumn 7, Issue , 2013, Pages 1101-1109

  Axelsson, Malin ^a,b   Cliffordson, Christina ^b   Lundbäck, Bo ^a   Lötvall, Jan ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY WEST   (Sweden)

Author keywords

Adherence; Health behavior; Individual differences; Medication concerns

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADULT; AGREABLENESS; ARTICLE; ASTHMA; ATTITUDE TO HEALTH; BELIEFS ABOUT MEDICINES QUESTIONNAIRE; CHARACTER STATE; CONSCIENTIOUSNESS; CONTROLLED STUDY; EXTRAVERSION; FEMALE; HEALTH BELIEF; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ADHERENCE REPORT SCALE; MEDICATION COMPLIANCE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROSIS; NEUROTICISM EXTRAVERSION AND OPENNESS TO EXPERIENCE FIVE FACTOR INVENTORY; PATIENT COMPLIANCE; PERSONALITY; QUESTIONNAIRE;

EID: 84886619448     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S49725     Document Type: Article

References (42)

1. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res.1999;47(6):555-567.
2. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res. 2008;64(1):41-46.
3. Phatak HM, Thomas J. Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother. 2006;40(10):1737-1742.
4. Menckeberg TT, Bouvy ML, Bracke M, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res. 2008;64(1):47-54.
5. Ponieman D, Wisnivesky JP, Leventhal H, Musumeci-Szabó TJ, Halm EA. Impact of positive and negative beliefs about inhaled corticosteroids on adherence in inner-city asthmatic patients. Ann Allergy Asthma Immunol. 2009;103(1):38-42.
6. Pervin LA, Cervone D. Personality: Theory and Research. 10th ed. Hoboken, NJ: Wiley; 2008.
7. Goodwin R, Engstrom G. Personality and the perception of health in the general population. Psychol Med. 2002;32(2):325-332.
8. Chapman B, Duberstein P, Lyness JM. Personality traits, education, and health-related quality of life among older adult primary care patients. J Gerontol B Psychol Sci Soc Sci. 2007;62(6):P343-P352.
9. Dubayova T, Nagyova I, Havlikova E, et al. Neuroticism and extraversion in association with quality of life in patients with Parkinson's disease. Qual Life Res. 2009;18(1):33-42.
10. Axelsson M, Emilsson M, Brink E, Lundgren J, Torén K, Lötvall J. Personality, adherence, asthma control and health-related quality of life in young adult asthmatics. Respir Med. 2009;103(7):1033-1040.
11. Christensen AJ, Smith TW. Personality and patient adherence: correlates of the five-factor model in renal dialysis. J Behav Med. 1995;18(3): 305-313.
12. Stilley CS, Sereika S, Muldoon MF, Ryan CM, Dunbar-Jacob J. Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Ann Behav Med. 2004;27(2):117-124.
13. O'Cleirigh C, Ironson G, Weiss A, Costa PT Jr. Conscientiousness predicts disease progression (CD4 number and viral load) in people living with HIV. Health Psychol. 2007;26(4):473-480.
14. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102(7): 1417-1426.
15. Bruce JM, Hancock LM, Arnett P, Lynch S. Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. J Behav Med. 2010;33(3):219-227.
16. Axelsson M, Brink E, Lundgren J, Lötvall J. The influence of personality traits on reported adherence to medication in individuals with chronic disease: an epidemiological study in West Sweden. PLoS One. 2011;6(3):e18241.
17. McCrae RR, Costa PT Jr. Personality in Adulthood: A Five-Factor Theory Perspective. 2nd ed. New York, NY: Guilford Press; 2003.
18. Costa PT Jr, McCrae RR. Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) Professional Manual. Odessa, FL: Psychological Assessment Resources; 1992.
19. Global Strategy for Asthma Management and Prevention [webpage on the Internet]. Global Initiative for Asthma (GINA); 2011. Available from: http://www.ginasthma.org/. Accessed November 29, 2012.
20. Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J. 2009;18(4):300-305.
21. Latry P, Pinet M, Labat A, et al. Adherence to anti-inflammatory treatment for asthma in clinical practice in France. Clin Ther. 2008; 30 Spec No:1058-1068.
22. Krishnan JA, Riekert KA, McCoy JV, et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med. 2004;170(12):1281-1285.
23. Lisspers K, Ställberg B, Hasselgren M, Johansson G, Svärdsudd K. Quality of life and measures of asthma control in primary health care. J Asthma. 2007;44(9):747-751.
24. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol. 2004;4(3):191-195.
25. Lötvall J, Ekerljung L, Rönmark EP, et al. West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res. 2009;10:94.
26. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1-24.
27. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17-32.
28. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173-1182.
29. Maruyama GM. Basics of Structural Equation Modelling. Thousand Oaks, CA: Sage Publications; 1998.
30. Gustafsson JE, Stahl PA. STREAMS 1.7 User's Guide. Mölndal, Sweden: Multivariate Ware; 1997.
31. Muthén LK, Muthén BO. Mplus User's Guide. Fifth Edition. Los Angeles, CA: Muthén and Muthén; 1998-2007.
32. Gustafsson JE, Stahl PA. STREAMS 3.0 User's Guide. Mölndal, Sweden: Multivariate Ware; 2005.
33. Brown TA. Confirmatory Factor Analysis for Applied Research. New York, NY: Guilford Press; 2006.
34. Muthén B, Kaplan D, Hollis M. On structural equation modeling with data that are not missing completely at random. Psychometrika. 1987;52(3):431-462.
35. Allison PD. Missing data techniques for structural equation modeling. J Abnorm Psychol. 2003;112(4):545-557.
36. Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147-177.
37. Park J, Jackson J, Skinner E, Ranghell K, Saiers J, Cherney B. Impact of an adherence intervention program on medication adherence barriers, asthma control, and productivity/daily activities in patients with asthma. J Asthma. 2010;47(10):1072-1077.
38. Bender BG, Apter A, Bogen DK, et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. J Am Board Fam Med. 2010;23(2):159-165.
39. Emilsson M, Berndtsson I, Lötvall J, et al. The influence of personality traits and beliefs about medicines on adherence to asthma treatment. Prim Care Respir J. 2011;20(2):141-147.
40. Bogg T, Roberts BW. Conscientiousness and health-related behaviors: a meta-analysis of the leading behavioral contributors to mortality. Psychol Bull. 2004;130(6):887-919.
41. Schumacker RE, Lomax RG. A Beginneŕs Guide to Structural Equation Modeling. 2nd ed. Mahwah, NJ: Lawrence Erlbaum Associates; 2004.
42. Mackinnon DP, Farichild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol. 2007;58:593-614.